OT mobile menu

Search form




A recent study published in European Urology suggests that patterns of treatment failure might help to predict what the next treatment should be for patients with metastatic renal cell carcinoma.

When CML patients develop resistance or intolerance to these drugs, transplant may be the only option.

Dr. Bobby Lazzara highlights a recent study published in JAMA Oncology on ethnic/racial disparity in genome sequencing and how researchers may be leaving this population behind.

The University of Illinois at Chicago, Northwestern University, the University of Chicago, and other affiliated hospitals and clinics have been selected to enroll 150,000 Illinoisans in the national Precision Medicine Initiative Cohort Program.

Obtaining blood biopsies instead of invasive tissue biopsies may be less risky for patients, faster, and cost less.

In this video we discuss 3-year overall survival data from the KEYNOTE-001 trial, which studied the anti–PD-1 antibody pembrolizumab in patients with advanced melanoma.

In this interview, Theodoros Teknos, MD, discusses the results of his current phase I trial of vorinostat (Zolinza) in advanced head and neck cancer.


Subscribe to Videos on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.